Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

California court says Novartis can be sued over generic drug injuries

California’s top court opened the door for consumers to sue Novartis AG and other makers of brand-name pharmaceutical products over injuries blamed on generic versions of the drugs manufactured by other companies.

Read More »

FDA approves La Jolla’s low blood pressure drug

La Jolla Pharmaceutical said the U.S. Food and Drug Administration approved its drug Giapreza to treat dangerously low blood pressure.

Read More »

Janssen Enters Worldwide Collaboration and License Agreement with Chinese Company Legend Biotech to Develop Investigational CAR-T Anti-Cancer Therapy

Janssen Biotech Inc. entered into a worldwide collaboration and license agreement with Legend Biotech USA Inc. and Legend Biotech Ireland Limited to develop, manufacture and commercialize a chimeric antigen receptor (CAR) T-cell drug candidate, LCAR-B38M, which specifically targets the B-cell maturation antigen.

Read More »

First-in-Human Trial of New Immunotherapy Approach Shows Efficacy in Antibiotic Resistance

SAB Therapeutics announced its first-in-human trial of new immunotherapy approach has shown efficacy in antibiotic-resistant bacteria based on a recent paper published online in Clinical Infectious Diseases.

Read More »

FDA Grants Breakthrough Therapy Designation for Avelumab in Combination with Inlyta in Advanced Renal Cell Carcinoma

Merck KGaA and Pfizer Inc. announced that the U.S. FDA granted Breakthrough Therapy Designation for avelumab in combination with Inlyta (axitinib) treatment-naïve patients with advanced renal cell carcinoma.

Read More »

FDA Approves New Diabetes Drug From Merck, Pfizer

The U.S. FDA approved Merck’s and Pfizer’s Steglatro (ertugliflozin), a sodium-glucose co-transporter 2 (SGLT2)- inhibitor, which will square off against established drugs in the market.

Read More »

U.S. life expectancy fell in 2016 as opioid overdoses surged: CDC

Life expectancy in the United States dipped in 2016 as the number of deaths due to opioid drug overdoses surged and total drug overdose deaths rose 21 percent to 63,600, the U.S. Centers for Disease Control and Prevention said.

Read More »

Five Keys for How You Can Make Marketing All About the Patient

There is a fundamental disconnect between companies and consumers: Healthcare brands often fail to address patients’ emotional journeys.

Read More »

Roche scores cancer drug approvals in Europe, U.S.

Swiss drugmaker Roche won approvals for two cancer drugs in Europe and the United States, shoring up its position in new medicines as it braces for falling sales of older products.

Read More »

FDA to fast track cell therapy for heart failure

The FDA will fast track the review of Australian drug developer Mesoblast Ltd.’s cell therapy treatment for heart failure patients under a new designation rolled out in December 2016.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!


Ad Right Bottom